Oticon Medical A/S, a leading innovator in the medical device industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 2013, the company has quickly established itself as a key player in the field of implantable hearing solutions, focusing on advanced technologies that enhance the quality of life for individuals with hearing loss.
Oticon Medical is renowned for its unique offerings, including the Ponto bone-anchored hearing system and the Neuro technology platform, which provide users with exceptional sound quality and clarity. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in audiology. With a strong market presence and a dedication to innovation, Oticon Medical continues to set benchmarks in the hearing healthcare sector.
+58 vs industry average
Oticon Medical A/S’s score of 87 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Oticon Medical A/S?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Real Estate Services has above-average carbon intensity
Industry performance
The Real Estate Services industry has reduced its overall emissions by 17% since 2018
Reported emissions
No reported emissions data is available for Oticon Medical A/S yet.
Oticon Medical A/S's reported carbon emissions
Oticon Medical A/S, headquartered in Denmark (DK), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Demant A/S, any climate commitments or emissions data would be cascaded from this parent organisation.
Demant A/S has established various climate initiatives, including Science Based Targets (SBTi) and participation in the Carbon Disclosure Project (CDP), which aim to reduce greenhouse gas emissions across its operations. However, specific reduction targets or achievements for Oticon Medical A/S are not detailed in the available information.
As part of its commitment to sustainability, Oticon Medical A/S aligns with the broader climate strategies of Demant A/S, which may include initiatives to enhance energy efficiency and reduce carbon footprints across its product lifecycle. Further details on specific emissions figures or reduction targets would require additional data from Demant A/S or related sources.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Oticon Medical A/S’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Oticon Medical A/S yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Oticon Medical A/S yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project